Variability of Human Immunodeficiency Virus Type 2 (HIV-2) Infecting Patients Living in France

Author： Damond F. Apetrei C. Robertson D.L. Souquiere S. Lepretre A. Matheron S. Plantier J.C. Brun-Vezinet F. Simon F.

Publisher： Elsevier

ISSN： 0042-6822

Source： Virology, Vol.280, Iss.1, 2001-02, pp. : 19-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interaction with Human Immunodeficiency Virus (HIV) Type 2 Predicts HIV Type 1 Genotype

By Sarr A.D. Sankale J.-L. Hamel D.J. Travers K.U. Gueye-Ndiaye A. Essex M. Mboup S. Kanki P.J.

Virology, Vol. 268, Iss. 2, 2000-03 ,pp. : 402-410

Elsevier

Access to resources Recommend Favorite

Identification of the nuclear localization signal of human immunodeficiency virus type 2 Vpx

By Belshan M. Ratner L.

Virology, Vol. 311, Iss. 1, 2003-06 ,pp. : 7-15

Elsevier

Access to resources Recommend Favorite

A CXC Chemokine Receptor, CXCR5/BLR1, Is a Novel and Specific Coreceptor for Human Immunodeficiency Virus Type 2

By Kanbe K. Shimizu N. Soda Y. Takagishi K. Hoshino H.

Virology, Vol. 265, Iss. 2, 1999-12 ,pp. : 264-273

Elsevier

Access to resources Recommend Favorite

Induction of Apoptosis by the Vpr Protein of Human Immunodeficiency Virus Type 1 Occurs Independently of G 2 Arrest of the Cell Cycle

By Nishizawa M. Kamata M. Mojin T. Nakai Y. Aida Y.

Virology, Vol. 276, Iss. 1, 2000-10 ,pp. : 16-26

Elsevier

Access to resources Recommend Favorite

Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2

By Morner A. Achour A. Norin M. Thorstensson R. Bjorling E.

Virus Research, Vol. 59, Iss. 1, 1999-01 ,pp. : 49-60

Elsevier

Access to resources Recommend Favorite